OpenURL Connection Search

Select item for more details and to access through your institution.

The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian Cohort.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 8, p. 5324, doi. 10.1245/s10434-024-15274-0
By:
- Zijlker, Lisanne P.;
- Chen, Henry;
- Spillane, Andrew J.;
- Gonzalez, Maria;
- Pennington, Thomas E.;
- Menzies, Alexander M.;
- Lo, Serigne N.;
- Ferguson, Peter;
- Rawson, Robert;
- Colebatch, Andrew J.;
- Stretch, Jonathan R.;
- Thompson, John F.;
- Ch'ng, Sydney;
- Nieweg, Omgo;
- Shannon, Kerwin F.;
- Long, Georgina V.;
- Scolyer, Richard A.;
- Saw, Robyn P. M.;
- van Akkooi, Alexander C. J.
Publication type:
Article
Baseline ultrasound and FDG‐PET/CT imaging in Merkel cell carcinoma.
Published in:
Journal of Surgical Oncology, 2023, v. 127, n. 5, p. 841, doi. 10.1002/jso.27193
By:
- Zijlker, Lisanne P.;
- Bakker, Max;
- van der Hiel, Bernies;
- Bruining, Annemarie;
- Klop, W. Martin C.;
- Zuur, Charlotte L.;
- Wouters, Michel W. J. M.;
- van Akkooi, Alexander C. J.
Publication type:
Article
Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial.
Published in:
2022
By:
- Rohaan, Maartje W.;
- Stahlie, Emma H. A.;
- Franke, Viola;
- Zijlker, Lisanne P.;
- Wilgenhof, Sofie;
- van der Noort, Vincent;
- van Akkooi, Alexander C. J.;
- Haanen, John B. A. G.
Publication type:
journal article
Avelumab treatment for patients with metastatic Merkel cell carcinoma can be safely stopped after 1 year and a PET/CT–confirmed complete response.
Published in:
Cancer (0008543X), 2024, v. 130, n. 3, p. 433, doi. 10.1002/cncr.35050
By:
- Zijlker, Lisanne P.;
- Levy, Sonja;
- Wolters, Wendy;
- van Thienen, Johannes V.;
- van Akkooi, Alexander C. J.;
- Tesselaar, Margot E. T.
Publication type:
Article
Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing.
Published in:
BioDrugs, 2022, v. 36, n. 3, p. 373, doi. 10.1007/s40259-022-00525-x
By:
- van Akkooi, Alexander C. J.;
- Zijlker, Lisanne P.;
- Wouters, Michel W. J. M.
Publication type:
Article
Stage III melanoma: role of lymph node dissection and (neo-)adjuvant systemic therapies.
Published in:
British Journal of Surgery, 2022, v. 109, n. 5, p. 397, doi. 10.1093/bjs/znac019
By:
- Zijlker, Lisanne P.;
- van Akkooi, Alexander C. J.
Publication type:
Article

Found: 6

The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian Cohort.

Baseline ultrasound and FDG‐PET/CT imaging in Merkel cell carcinoma.

Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial.

Avelumab treatment for patients with metastatic Merkel cell carcinoma can be safely stopped after 1 year and a PET/CT–confirmed complete response.

Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing.

Stage III melanoma: role of lymph node dissection and (neo-)adjuvant systemic therapies.